The diagnosis of hepatosplenic candidiasis by DNA analysis of tissue biopsy and serum

Journal of Clinical Pathology

Volumn 57, Issue 7, 2004, Pages 764-765

  Kirby, A ^a   Chapman, C ^a   Hassan, I ^a   Burnie, J ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; DNA;

ADULT; ANAMNESIS; ANTIMICROBIAL THERAPY; ARTICLE; BIOPSY; BLOOD CULTURE; CANDIDIASIS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC TEST; DNA DETERMINATION; FEMALE; FUNGAL DETECTION; HEPATITIS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SPECIES IDENTIFICATION; SPLEEN BIOPSY; SPLEEN DISEASE;

ADULT; BIOPSY; CANDIDA; CANDIDIASIS; DNA, FUNGAL; FEMALE; HUMANS; LIVER DISEASES; POLYMERASE CHAIN REACTION; SPLENIC DISEASES;

EID: 3142588883     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.015347     Document Type: Article

References (10)

1. Turenne CY, Sanche SE, Hoban DJ, et al. Rapid identification of fungi using the ITS2 genetic region and an automated fluorescent capillary electrophoresis system. J Clin Microbiol 1999;37:1846-51.
2. Guiver M, Levi K, Oppenheim BA. Rapid identification of candida species by TaqMan PCR. J Clin Pathol 2001;54:362-6.
3. Morace G, Pagano L, Sanguinetti M, et al. PCR-restriction enzyme analysis for detection of candida DNA in blood from febrile patients with haematological malignancies. J Clin Microbiol 1999;37:1871-5.
4. Sallah S, Semelka RC, Wehbie R, et al. Hepatosplenic candidiasis in patients with acute leukaemia. Br J Haematol 1999;106:697-701.
5. Marco F, Danes C, Almela M, et al. Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of candida bloodstream isolates. Results from a six-year study (1996-2001). Diagn Microbiol Infect Dis 2003;46:259-64.
6. Barchiesi F, Schimizzi AM, Fothergill AW, et al. In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of candida species. Eur J Clin Microbiol Infect Dis 1999;18:302-4.
7. Pfaller MA, Diekema DJ, Messer SA, et al. International Fungal Surveillance Participant Group. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against candida species infrequently isolated from blood. J Clin Microbiol 2003;41:78-83.
8. White CT, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol 1998;11:382-402.
9. Mora-Duarte J, Betts R, Rotstein C, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002;347):2020-9.
10. Walsh TJ. Echinocandins - an advance in the primary treatment of invasive candidiasis. N Engl J Med 2002;347:2070-2.